Usana Health Sciences
USNA
169 hedge funds and large institutions have $647M invested in Usana Health Sciences in 2023 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 49 increasing their positions, 74 reducing their positions, and 22 closing their positions.
1,361% more call options, than puts
Call options by funds: $643K | Put options by funds: $44K
0.93% less ownership
Funds ownership: 54.09% → 53.16% (-0.93%)
2% less capital invested
Capital invested by funds: $658M → $647M (-$11.5M)
4% less funds holding
Funds holding: 176 → 169 (-7)
32% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 22
34% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 74
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$3.44M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.23M |
| 3 |
Man Group
London,
United Kingdom
|
+$2.72M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
+$2.09M |
| 5 |
American Century Companies
Kansas City,
Missouri
|
+$1.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$5.25M |
| 2 |
First Trust Advisors
Wheaton,
Illinois
|
-$3.38M |
| 3 |
BlackRock
New York
|
-$2.9M |
| 4 |
Goldman Sachs
New York
|
-$2.66M |
| 5 |
Pzena Investment Management
New York
|
-$1.8M |
USNA Hedge Fund Activity: Q2 2023 in Review
169 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q2 2023, worth a combined $647M — down 1.7% from $658M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of USNA and 15 opened new positions — a net loss of 7 holders — while 74 trimmed existing stakes and 49 added.
The largest buyer was JP Morgan Chase, adding an estimated $3.44M. The largest seller was UBS Group, cutting an estimated $5.25M.
- 169 institutional investors held Usana Health Sciences (USNA) as of Q2 2023, down from 176 in Q1 2023.
- Funds reported $647M of Usana Health Sciences stock for Q2 2023, down 1.7% quarter-over-quarter.
- 15 funds opened new Usana Health Sciences positions in Q2 2023 and 22 closed out, a net change of -7 holders.
- The largest Usana Health Sciences buyer in Q2 2023 was JP Morgan Chase, an estimated $3.44M added.
- The largest Usana Health Sciences seller in Q2 2023 was UBS Group, an estimated $5.25M sold.
Based on aggregated 13F filings for Q2 2023.